Fosfomycin Disodium Patent Expiration

Fosfomycin Disodium was first introduced by Meitheal Pharmaceuticals Inc in its drug Contepo on Oct 22, 2025.


Fosfomycin Disodium Patents

Given below is the list of patents protecting Fosfomycin Disodium, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Contepo US11541064 Jan 30, 2039 Meitheal
Contepo US9345717 Oct 27, 2034 Meitheal
Contepo US10086006 Oct 12, 2034 Meitheal



Fosfomycin Disodium's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Fosfomycin Disodium Generic API Manufacturers

Given below is the list of companies who have filed for Fosfomycin Disodium generic, along with the locations of their manufacturing plants worldwide.